View Older Stories

Jan 20, 2026 12:01PM Raymond James Reiterates Outperform Rating on Legend Biotech Corp. (LEGN) After FDA Draft Guidance

Jan 15, 2026 07:11AM Deutsche Bank on Legend Biotech Corp. (LEGN): 'Most incremental, in our view, LEGN will share first patient data for its in-vivo CAR T program by YE26'

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 17, 2025 07:23AM Legend Biotech (LEGN) Reiterated at Overweight by Cantor Fitzgerald

Dec 9, 2025 12:38PM RBC Capital Defends Legend (LEGN) For Second Day in a Row As Stock Continues to Push Lower

Dec 8, 2025 07:49AM RBC Capital on Legend Biotech Corp. (LEGN): 'We Would Be Buyers'

Dec 8, 2025 02:54AM Legend Biotech reports 50-month survival data for CARVYKTI in myeloma

Nov 19, 2025 06:45AM Breakthrough Properties partners with Eli Lilly for Philadelphia lab space

Oct 17, 2025 06:45AM Legend Biotech Corp. (LEGN) PT Lowered to $60 at H.C. Wainwright

Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview

Oct 7, 2025 06:10AM Cantor Fitzgerald Starts Legend Biotech Corp. (LEGN) at Overweight

Sep 12, 2025 06:29AM RBC Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)

Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Aug 27, 2025 06:08AM Cantor Fitzgerald Assumes Legend Biotech Corp. (LEGN) at Overweight

Aug 12, 2025 10:20AM Legend Biotech Corp. (LEGN) PT Raised to $77 at RBC Capital on Growth Potential

Aug 11, 2025 12:16PM Legend Biotech (LEGN) Tops Q2 EPS by 15c

Jul 17, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

Jul 17, 2025 05:35AM Goldman Sachs Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

Jul 16, 2025 12:38PM JNJ results have positive read-through for Legend Biotech (LEGN) - Barclays

Jul 16, 2025 07:35AM Legend Biotech (LEGN) Announces Preliminary Sales for CARVYKTI

Jul 3, 2025 09:24AM Legend Biotech Corp. (LEGN) PT Lowered to $54 at UBS

Jul 2, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

Jul 1, 2025 06:00AM BMO lists 3 top biotech ideas for H2

Jun 3, 2025 10:45AM Legend Biotech (LEGN) Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

Jun 2, 2025 07:03AM RBC Capital: 'Legend Biotech Corp. (LEGN) Still Undervalued'

Jun 2, 2025 05:08AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)

May 22, 2025 05:25PM Legend Biotech (LEGN) announces new data evaluating CARVYKTI

May 16, 2025 10:32AM RBC Capital on Legend Biotech Corp. (LEGN): 'We See A Compelling Valuation'

May 14, 2025 01:56AM Legend Biotech (LEGN) Misses Q1 EPS by 6c

May 13, 2025 04:38PM TD Cowen Reiterates Buy Rating on Legend Biotech Corp. (LEGN), PT $62, 'We Like The Profile At These Levels'

May 13, 2025 04:00PM Legend Biotech Corp. (LEGN) PT Lowered to $71 at Truist Securities

May 13, 2025 03:26PM Raymond James Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)

Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets

Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'

Apr 10, 2025 10:07AM TD Cowen on Legend Biotech Corp. (LEGN): 'Carvykti Should Beat in Q1, Easing Investor Concerns'

Apr 8, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

Mar 12, 2025 10:56AM RBC Capital on Legend Biotech Corp. (LEGN): 'See An Attractive Entrypoint With Strong 2025 Growth Potential'

Mar 12, 2025 10:18AM BMO Capital Reiterates Outperform on Legend Biotech Corp. (LEGN), Sees 'Upside in 2025'

Mar 12, 2025 09:25AM Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)

Mar 12, 2025 06:39AM Legend Biotech Corp. (LEGN) PT Raised to $75 at H.C. Wainwright

Mar 11, 2025 04:57PM Legend Biotech (LEGN) Tops Q4 EPS by 9c

Jan 22, 2025 12:27PM Legend Biotech Corp. (LEGN) PT Lowered to $91 at Jefferies

Jan 22, 2025 11:11AM Goldman Sachs Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

Jan 21, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

Jan 10, 2025 12:33PM Legend Biotech (LEGN) Strength Tied to Unconfirmed Chatter

Dec 30, 2024 11:36AM Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)

Dec 22, 2024 04:00AM Barclays shares outlook for Biotech in 2025, names preferred stocks

Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025

Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech

View Older Stories